Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported consolidated financial results for the quarter ended June 30, 2016 and reviewed recent progress with its approved and investigational …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the U.S.
AEterna Zentaris Inc. (USA) In a research issued yesterday, Maxim analyst Jason McCarthy reiterated a Buy rating on shares of AEterna Zentaris Inc.
Analysts have mixed sentiments on MannKind Corporation (NASDAQ:MNKD) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). It’s a long fall from the top as MannKind investors …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that it received a Complete Response Letter from theU.S.
Analysts weigh in with bullish sentiments on both Incyte Corporation (NASDAQ:INCY) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) following the termination of the drug trial …
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported consolidated financial results for the quarter endedDecember 31, 2015. Vertex also reiterated its financial guidance for total 2016 KALYDECO® (ivacaftor) …
J.P.
Arrowhead Research Corp On September 24, 2015 shares of Arrowhead Research Corp (NASDAQ:ARWR) were up as much as 20% after announcing positive phase …
